BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28497562)

  • 1. Different aggregation states of a nuclear localization signal-tagged 25-kDa C-terminal fragment of TAR RNA/DNA-binding protein 43 kDa.
    Kitamura A; Yuno S; Muto H; Kinjo M
    Genes Cells; 2017 Jun; 22(6):521-534. PubMed ID: 28497562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity.
    Kitamura A; Nakayama Y; Shibasaki A; Taki A; Yuno S; Takeda K; Yahara M; Tanabe N; Kinjo M
    Sci Rep; 2016 Jan; 6():19230. PubMed ID: 26757674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation of the 35-kDa fragment of TDP-43 causes formation of cytoplasmic inclusions and alteration of RNA processing.
    Che MX; Jiang YJ; Xie YY; Jiang LL; Hu HY
    FASEB J; 2011 Jul; 25(7):2344-53. PubMed ID: 21450909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient and dynamic nuclear localization of green fluorescent protein via RNA binding.
    Kitamura A; Nakayama Y; Kinjo M
    Biochem Biophys Res Commun; 2015 Jul; 463(3):401-6. PubMed ID: 26032495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular chaperone HSP70 prevents formation of inclusion bodies of the 25-kDa C-terminal fragment of TDP-43 by preventing aggregate accumulation.
    Kitamura A; Iwasaki N; Kinjo M
    Cell Stress Chaperones; 2018 Nov; 23(6):1177-1183. PubMed ID: 30099725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate Attenuates 25-kDa C-Terminal Fragment of TDP-43-Induced Neuronal Toxicity via Suppressing Endoplasmic Reticulum Stress and Activating Autophagy.
    Wang X; Ma M; Teng J; Che X; Zhang W; Feng S; Zhou S; Zhang Y; Wu E; Ding X
    Int J Biol Sci; 2015; 11(7):752-61. PubMed ID: 26078717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The molecular mechanisms of intracellular TDP-43 aggregates].
    Nonaka T; Arai T; Hasegawa M
    Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43).
    Hans F; Eckert M; von Zweydorf F; Gloeckner CJ; Kahle PJ
    J Biol Chem; 2018 Oct; 293(41):16083-16099. PubMed ID: 30120199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of amyloid fibrils by the C-terminal fragments of TDP-43 in amyotrophic lateral sclerosis.
    Chen AK; Lin RY; Hsieh EZ; Tu PH; Chen RP; Liao TY; Chen W; Wang CH; Huang JJ
    J Am Chem Soc; 2010 Feb; 132(4):1186-7. PubMed ID: 20055380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing TDP-43
    Laos V; Do TD; Bishop D; Jin Y; Marsh NM; Quon B; Fetters M; Cantrell KL; Buratto SK; Bowers MT
    ACS Chem Neurosci; 2019 Sep; 10(9):4112-4123. PubMed ID: 31430111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Protein Aggregation using Fluorescence Correlation Spectroscopy.
    Kitamura A; Fujimoto A; Kinjo M
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33970128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 and FUS: a nuclear affair.
    Dormann D; Haass C
    Trends Neurosci; 2011 Jul; 34(7):339-48. PubMed ID: 21700347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALS-causing cleavages of TDP-43 abolish its RRM2 structure and unlock CTD for enhanced aggregation and toxicity.
    Wei Y; Lim L; Wang L; Song J
    Biochem Biophys Res Commun; 2017 Apr; 485(4):826-831. PubMed ID: 28257838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
    Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
    Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PABPN1 suppresses TDP-43 toxicity in ALS disease models.
    Chou CC; Alexeeva OM; Yamada S; Pribadi A; Zhang Y; Mo B; Williams KR; Zarnescu DC; Rossoll W
    Hum Mol Genet; 2015 Sep; 24(18):5154-73. PubMed ID: 26130692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear trafficking of the POZ-ZF protein Znf131.
    Donaldson NS; Daniel Y; Kelly KF; Graham M; Daniel JM
    Biochim Biophys Acta; 2007 Apr; 1773(4):546-55. PubMed ID: 17306895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular properties of TAR DNA binding protein-43 fragments are dependent upon its cleavage site.
    Furukawa Y; Kaneko K; Nukina N
    Biochim Biophys Acta; 2011 Dec; 1812(12):1577-83. PubMed ID: 21946215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of transforming growth factor-β/Smad signaling reduces aggregate formation of mislocalized TAR DNA-binding protein-43.
    Nakamura M; Kaneko S; Ito H; Jiang S; Fujita K; Wate R; Nakano S; Fujisawa J; Kusaka H
    Neurodegener Dis; 2013; 11(4):182-93. PubMed ID: 22797246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
    BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.